Selective inhibitory effect of a TIBO compound, R82150, on the activity of HIV-1 reverse transcriptase

Ono K; Hideo Nakane; Rudi Pauwels; Zeger Debyser; K Andries; Patricia A. Janssen; De Clercq Erik

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article1991

The TIBO-site on HIV-1 reverse transcriptase represents a new target for anti-HIV chemotherapy

Rudi Pauwels, Zeger Debyser, Koen Andries, Mitsuo Baba, Dominique Schols, Michael J. Kukla, Jan Desmyter, Paul A. J. Janssen, De Clercq Erik

Article1991

New antiviral target on HIV-1 reverse transcriptase revealed by TIBO derivatives

Zeger Debyser, Rudi Pauwels, K Andries, Jan Desmyter, Michael J. Kukla, Paj Janssen, De Clercq Erik

Article1993

HIV-1-Specific Reverse Transcriptase Inhibitors Show Differential Activity against HIV-1 Mutant Strains Containing Different Amino Acid Substitutions in the Reverse Transcriptase

Jan Balzarini, Anna Karlsson, María‐Jesús Pérez‐Pérez, Lotta Vrang, Johan Walbers, Hong Zhang, Bo Öberg, Anne‐Mieke Vandamme, Marı́a-José Camarasa, De Clercq Erik

Article2005

Structure-activity relationship studies on a novel family of specific HIV-1 reverse transcriptase inhibitors

Aylee Cordeiro, M C Bonache, De Clercq Erik, Jan Balzarini, Marı́a-José Camarasa, Ana San‐Félix

Article2003

Structure-Activity Relationship Studies on a Novel Family of Specific HIV-1 Reverse Transcriptase Inhibitors

Marı́a-Cruz Bonache, Cristina Chamorro, Esther Lobatón, De Clercq Erik, Jan Balzarini, Sonsoles Velázquez, Marı́a-José Camarasa, Ana San‐Félix